Only SBS3b strongly predicts survival in ovarian cancer patients, exceeding other genetic markers
➕utility of MMRd signatures also improved with indel+SNV joint inference
Read more: 👇
genomemedicine.biomedcentral.com/articles/10....
Only SBS3b strongly predicts survival in ovarian cancer patients, exceeding other genetic markers
➕utility of MMRd signatures also improved with indel+SNV joint inference
Read more: 👇
genomemedicine.biomedcentral.com/articles/10....